Fig. 7From: Efficacy and safety of adjuvant EGFR-TKIs for resected non-small cell lung cancer: a systematic review and meta-analysis based on randomized control trialsComparison of RRs of grade 1–5 AEs and grade ≥ 3 AEs between adjuvant EGFR-TKIs versus adjuvant chemotherapy/placeboBack to article page